BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Anulex Technologies, Inc. Raises $10.2 Million in Series D Financing and Appoints New Senior Management


6/15/2009 7:42:15 AM

Bookmark and Share

MINNEAPOLIS--(BUSINESS WIRE)--Anulex Technologies, Inc., a privately held medical device manufacturer focusing on spinal disc Preservation & Anular RepairTM products, announced the close of its fourth round of private equity financing, totaling approximately $10.2 million. Investors leading the round include Affinity Capital, Delphi Ventures, MB Venture Partners, New Enterprise Associates, SightLine Partners and Split Rock Partners.

Commenting on the financing, Rich Lunsford, Anulex’s President and Chief Executive Officer, said, “This financing will give us the ability to complete the enrollment and follow-up phases of our ground-breaking Xclose post market clinical study with the goal of providing further evidence to support the benefits of preservation and repair of the anulus. It will also provide additional investment for our U.S. commercialization efforts and further support the company’s innovative research and development strategy.”

In addition, two new Vice Presidents have recently been appointed to Anulex’s Senior Management Team. David M. Noel was appointed Vice President of Finance and Chief Financial Officer in February 2009. Prior to joining Anulex, Mr. Noel served in a similar role at Lifecore Biomedical, Inc. a privately held company which designed and marketed dental implants and manufactures hyaluronan for use in various surgical markets. Matt Meyer was appointed Vice President of Sales and Marketing, in March 2009. Previously, Mr. Meyer served as Vice President of Marketing for KFx Medical, a privately held sports medicine device company. Prior to this position, Mr. Meyer served for over ten years, in a variety of senior marketing and sales positions, with Medtronic Spinal and Biologics.

“We are delighted by the additions of David and Matt to the Anulex team. Both bring excellent experience in the medical device field as we continue to expand our market leadership position in anular repair”, said Mr. Lunsford.

About Anulex

Anulex Technologies, Inc. is a privately held company dedicated to the development and commercialization of unique and proprietary soft tissue repair products with primary interests in treatments for the soft tissues of the spine. Back pain afflicts four out of every five individuals at some point during their life, and it is a major cause of disability. To date, Anulex has raised approximately $48.4 million through four rounds of financing to support these efforts. More information on the Company can be found at www.anulex.com.

Xclose, Anulex, and Preservation & Anular Repair are trademarks of Anulex Technologies, Inc.

Contact:

Anulex Technologies, Inc. Julie Osterberg, 952-224-4043 josterberg@anulex.com

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->